| DDS | Drug delivery system |
| PNI | Peripheral nerve injury |
| SCs | Schwann cells |
| NTs | Neurotrophic factors |
| NGC | Nerve guidance channel |
| NGF | Nerve growth factor |
| MPs | Microparticles |
| NPs | Nanoparticles |
| PLGA | Poly(lactic-co-glycolic acid) |
| GDNF | Glia cell-derived neurotrophic factor |
| BDNF | Brain-derived nerve factor |
| BSA | Bovine serum albumin |
| EPO | Erythropoietin |
| NT-3 | Neurotrophin 3 |
| NT4/5 | Neurotrophin 4/5 |
| TrKA | Tyrosine kinases receptor A |
| TrkB | Tyrosine kinases receptor B |
| DS | Delivery system |
| CNTF | Ciliary neurotrophic factor |
| DRG | Dorsal root ganglia |
| FGF | Fibroblast growth factor |
| FK506 | Tacrolimus |
| TM | Thrombomodulin |
| 4-AP | 4-aminopyridine |
| MSs | Microspheres |
| PEG | Polyethylene glycol |
| PCL | Polycaprolactone |
| PLLA | Poly(L-lactic acid) |
| CNAP | Compound nerve action potential |
| CMAP | Compound muscle action potential |
| NCV | Nerve conduction velocity |
| HNTs | Halloysite nanotubes |
| MNP | magnetic nanoparticle |
| VEGF | Vascular endothelial growth factor |
| PDLLA | Poly (D, L- lactic acid) |
| MLT | Melatonin |
| MAPK | Mitogen-activated protein kinase |
| P(LLA-CL) | Poly(L-lactic acid-co-ε-caprolactone) |
| HFMF | High-frequency magnetic field |